Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Cyproterone acetate with estradiol improved women's self-confidence and emotional well-being without a difference between oral or transdermal methods, but younger women preferred the oral method.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Reducing gefitinib dosage improved hair loss, but scarring remained.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Lower TNF-α levels in PRP may predict better treatment outcomes for bladder conditions.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Finasteride and methadone don't increase advanced liver disease risk in HCV+ male veterans.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Using finasteride with TIP extends time off period for prostate cancer patients.

Prostaglandin F2α may help treat hair loss by promoting hair growth.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

PRP and IT are equally effective for treating localized alopecia areata, but PRP causes more pain and bleeding.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.